May 13, 2025 | Client Services, Medical writer, New hires, Team
Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning
We’re delighted to announce several new additions to the Cuttsy+Cuttsy team, as we continue to grow and strengthen our capabilities.
Joining us this month are four talented individuals who bring fresh skills, energy, and expertise to help us deliver impactful solutions for our clients, patients, and the wider communities we serve.
Please give a warm welcome to our newest team members:
We’re also delighted to welcome back Sally Ram, who returns to Cuttsy+Cuttsy after two years to rejoin as an Account Director. Sally brings with her valuable experience from her time away and is ready to make an immediate impact in her new role.
Speaking about her return, Sally shared, “It feels fantastic to be back at Cuttsy+Cuttsy! I’ve missed the incredible team, and I’m excited to get stuck into my new role, building meaningful connections and delivering work that truly makes a difference.”
With these new faces on board (and one familiar one!), we’re more excited than ever for the bright future ahead. Please join us in welcoming Michelle, Jay, Emily, and Sally. We look forward to seeing all the great things they’ll accomplish!
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
